Last Updated: Wednesday, June 05, 2013, 20:20
Cipla Wednesday said it has granted the global commercialisation rights for its nasal spray 'Dymista' to Swedish partner Meda AB except for certain geographies.
Last Updated: Monday, June 03, 2013, 12:15
Sun Pharmaceutical’s share prices fell as much as 2.23 percent on Monday amidst reports that it is in talks to buy Sweden's Meda AB for over $5 billion.
Last Updated: Sunday, June 02, 2013, 15:02
Drug major Sun Pharmaceutical Industries is said to be in talks to buy Sweden's pharma firm Meda AB in a deal worth up to USD 5 billion, according to media reports.
Last Updated: Saturday, June 01, 2013, 09:08
The pharma company’s stocks last traded down 2.54% at Rs 1,045.50 for the week ended yesterday.
more videos >>